Expression of EGFR is closely related to reduced 3-year survival rate in Chinese female NSCLC

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 2225-2231

  Sun, Guangyuan ^a   Liu, Bing ^b   He, Jin ^a   Zhao, Xuewei ^a   Li, Bing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The People's Hospital of Putuo District   (China)

Author keywords

Carcinoma, non small cell lung; Female; Immunohistochemistry; Receptors, vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

AGE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; SURVIVAL; TUMOR VOLUME; ADULT; AGED; CHINA; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE;

EID: 84938594323     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.894786     Document Type: Article

References (20)

1. Travis WD, Lubin J, Ries L et al: Epidermal growth factor receptor-tyrosine kinase inhibitors for non-small-cell lung cancer patients aged 80 years or older: A retrospective analysis. Mol Clin Oncol, 2015; 3: 403–7
2. Patel JD: Lung cancer in women. J Clin Oncol, 2005; 23: 3212–18
3. North CM, Christiani DC: Women and lung cancer: what is new? Semin Thorac Cardiovasc Surg, 2013; 25: 87–94
4. Cheng PC, Cheng YC: Correlation between familial cancer history and epidermal growth factor receptor mutations in Taiwanese never smokers with non-small cell lung cancer: a case-control study. J Thorac Dis, 2015; 7: 281–87
5. Hsieh RK, Lim KH, Kuo HT et al: Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest, 2005; 128: 317–31
6. Marshall AL, Christiani DC: Genetic susceptibility to lung cancer – light at the end of the tunnel? Carcinogenesis, 2013; 34: 487–502
7. Yang Y, Luo J, Zhai X et al: Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: a meta-analysis. Int J Cancer, 2014; 135: 1417–24
8. Krzyzanowska MK, Barbera L, Elit L et al: Identifying population-level indicators to measure the quality of cancer care for women. Int J Qual Health C, 2011; 23: 554–64
9. Hirsch FR, Varella-Garcia M, McCoy J et al: Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. J Clin Oncol, 2005; 23: 6838–68
10. Delaney C, Frank S, Huang RS: Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond. Chin J Cancer, 2015; 34(1): 7
11. Steuer CE, Ramalingam SS: Targeting EGFR in lung cancer: Lessons learned and future perspectives. Mol Aspects Med, 2015; pii: S0098-2997(15)00034-5
12. Yang X, Yang K, Kuang K: The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung cancer: a systematic review. Curr Oncol Rep, 2014; 16: 390
13. Wu P, Zhang J, Li R: Expressions of epidermal growth factor receptor (EGFR) and Ki67 in non-small cell lung cancer and correlative research. Chinese Journal of Cancer Prevention, 2004; 11: 913–18
14. Ohsaki Y, Tanno S, Fujita Y et al: Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep, 2000; 7: 603–60
15. Feng ZY, Hu HC: Expressions of epidermal growth factor receptor (EGFR) in lung cancer tissues. Suzhou University Journal of Medical Science, 2003; 23: 692–94
16. Lynch TJ, Bell DW, Sordella R et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med, 2004; 350: 2129–39
17. Suzuki M, Shigematsu H, Hiroshima K et al: Epidermal growth factor receptor expression status in lung cancer correlates with its mutation. Hum Pathol, 2005; 36: 1127–34
18. Zhou CC, Zhao YM, Tang L: Clinical significance of epidermal growth factor receptor mutation in chinese patients with non-small cell lung cancer. Tumor, 2005; 25: 458–61
19. Suda K, Mitsudomi T: Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity. Arch Toxicol, 2015 [Epub ahead of print]
20. Ahn JH, Kim SW, Hong SM: Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma. J Korean Med Sci, 2004; 19: 529–35